The FXR controls several pathways involved in the pathogenesis of MASH, postulated to be independent of, and complementary to, THRβ agonism, including bile acid synthesis and circulation, lipid and glucose metabolism, inflammation, fibrosis and gut barrier integrity22,41. Here, THRB is linked to metabolic dysfunction-associated steatohepatitis.